Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
Revenue$25.4 billion+5.9% YoY
EPS$0.09
Outlookraisedguidance
Company · JNJ
Earnings coverage
Widgets by TradingView. They load only when you click, so the page stays fast.
Forensic equity research on US stocks. No spam, unsubscribe anytime.